1-15 of 15 Search Results for

plasma

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
×Close Modal
Sort by
Journal Article
Journal of Health Politics, Policy and Law (1 August 1984) 8 (4): 814–815.
Published: 01 August 1984
... Titmuss, Book Reviews 815 however, he has a genuine market to attack. A thriving international trade in plasma-derived blood products has developed since The Gift Relationship was published in 1970. Hagen condemns this trade, but seems unpersuaded...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2002) 27 (6): 977–1000.
Published: 01 December 2002
... . Available on-line at www.hhs.gov/bloodsafety/summaries/sumaug97.html . ———. 1998 . Transcript of meeting held 27–28 August . Available on-line at www.hhs.gov/bloodsafety/transcripts/19980928.html . American Blood Resources Association (ABRA) (now the Plasma Protein Therapeutics Association [PPTA...
Journal Article
Journal of Health Politics, Policy and Law (1 February 1978) 3 (1): 5–10.
Published: 01 February 1978
... Implementation Plan; Request for Com- ments,” Federal Register, March 8. 1974. 9326-30. 7. These include the Ad Hoc Clearinghouse Issues Study Committee; Ad Hoc Committee on Plasma and Plasma Supply; Committee for Commonality in Blood Banking Automa- tion; Committee on Utilization of...
Journal Article
Journal of Health Politics, Policy and Law (1 February 1988) 13 (1): 167–178.
Published: 01 February 1988
...: The Case of Voluntary Blood Donorship. Journal of Social Policy 10 : 53 -79. London , P. , and B. M. Hemphill. 1965 . The Motivations of Blood Donors. Transfusion 14 : 559 -68. National Institutes of Health. 1986 . The Impact of Routine HTLV-1V Antibody Testing of Blood and Plasma...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2016) 41 (3): 463–472.
Published: 01 June 2016
... . “ Levels of Plasma Trans-Fatty Acids in non-Hispanic White Adults in the United States in 2000 and 2009 .” Journal of the American Medical Association 307 , no. 6 : 562 – 63 . Volpp K. G. , John L. K. , Troxel A. B. , Norton L. , Fassbender J. , and Loewenstein G...
Journal Article
Journal of Health Politics, Policy and Law (1 April 1991) 16 (2): 215–250.
Published: 01 April 1991
Journal Article
Journal of Health Politics, Policy and Law (1 April 1998) 23 (2): 265–290.
Published: 01 April 1998
... improvement drugs compared to previously available drugs, provide considerable improvement in “Irreplaceable” drugs, drugs used to treat 30 conditions selected chronic and compassionate use drugs plasma substitutes, tetanus drugs, and others. conditions medical The 30...
Journal Article
Journal of Health Politics, Policy and Law (1 August 1995) 20 (4): 973–1000.
Published: 01 August 1995
... industry. All U.S. firms holding FDA licenses now are producing vaccines, and very few licensed firms pose a credible threat of entry. 5. Biological agents include bacterial and viral vaccines, antigens, antitoxins, toxoids, and allogenic extracts as well as sera, plasma, and other blood derivatives for...
Journal Article
Journal of Health Politics, Policy and Law (1 August 1994) 19 (4): 813–835.
Published: 01 August 1994
... Information in Health Care. Journal of Personality and Social Psychology 39 ( 5 ): 977 -90. Lederman , R. P. , E. Lederman, B. Work, and D. McCann. 1978 . The Relationship of Maternal Anxiety, Plasma Catecholamines, and Plama Cortisol to Progress in Labor. American Journal of Obstetrics and...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2009) 34 (6): 863–898.
Published: 01 December 2009
..., within both the whole blood market and the blood plasma market, innovation fails to correlate with how collection was organized. Private and public actors, as well as for-profit and nonprofit, attempted to slow innovation in different countries. Nor do the activities of these organizations...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2012) 37 (6): 1057–1089.
Published: 01 December 2012
Journal Article
Journal of Health Politics, Policy and Law (1 February 1989) 14 (1): 87–113.
Published: 01 February 1989
Journal Article
Journal of Health Politics, Policy and Law (1 February 2015) 40 (1): 41–71.
Published: 01 February 2015
... ; ZGWSNJ 2011: 438). Occasionally, conditional financing is used in a negative way to encourage policy change favored by the donor institutions. In September 2002, China submitted a proposal to the Global Fund asking the organization to cover the entire cost of treating HIV-infected former plasma...
Journal Article
Journal of Health Politics, Policy and Law (1 August 2017) 42 (4): 607–644.
Published: 01 August 2017
..., the FDA moved from product data to clinical data over the space of thirty years, and all bioequivalence and biosimilarity studies are today carried out with clinical data: hematological tests using plasma concentrations of the generic drug and the pioneer predicate. We can conclude from the review...
Journal Article
Journal of Health Politics, Policy and Law (1 August 2011) 36 (4): 717–755.
Published: 01 August 2011
... sell their blood plasma. As Benjamin Hippen argues, moral opposition should not necessarily equate to legal prohibi- tion, because in a morally pluralistic society individuals should be free to “[actualize] their moral commitments in market relationships, whether by participation in or...